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Matters Arising 
Reevaluation of the Roles 
of Protein S and Gas6 as Ligands 
for the Receptor Tyrosine Kinase 
Rse/Tyro 3 
Recently, Stitt et al. (1995) reported that protein S (PS), 
but not Gas6, is a potent ligand for the receptor tyrosine 
kinase known as Rse, Tyro 3, Brt, Sky, and Tif (hereafter 
referred to as Rse/Tyro 3). PS is an abundant serum pro- 
tein previously characterized as an essential anticoagu- 
lant. Gas6, which was identified as a gene whose expres- 
sion is increased by growth arrest, shares 43% amino acid 
identity and overall domain organization with PS (Manfio- 
letti et al., 1993). Stitt et al. (1995) based their conclusions 
on experiments describing interspecies interactions of bo- 
vine Gas6 with murine Rse/Tyro 3 (mRse/Tyro 3) and on 
interactions of bovine and human PS (hPS) with mRse/ 
Tyro 3. Consistent with the results of Stitt et al. (1995), 
we identified bovine PS as a ligand for human Rse/Tyro 
3 (hRse/Tyro 3), and we also found that hPS can act as 
a ligand for mRse/Tyro 3. However, when we analyzed 
the more relevant intraspecies interactions, we obtained 
different results. We found that human Gas6 (hGas6), but 
not hPS, acted as a potent ligand for hRse/Tyro 3 (Figure 
1). The hRse/Tyro 3 we have studied is very likely the true 
homolog of mRse/Tyro 3 since they share 90% amino acid 
identity and a similar expression pattern (Mark et al., 1994; 
Lai et al., 1994). 
To characterize the Rse/Tyro 3 ligand, we constructed 
soluble receptor proteins containing the extraceltular do- 
main of either hRse/Tyro 3 or mRseFryro 3 fused to the 
Fc portion of human immunoglobulin G1 (hRse-lgG and 
mRse-lgG). A similar fusion protein (termed Tyro 3-Fc) 
was utilized by Stitt et al. (1995) to characterize the binding 
of bovine Gas6 and hPS to mRse/Tyro 3. We first deter- 
mined whether hRse-lgG or mRse-lgG differed in its abil- 
ity to bind to hPS or hGas6 containing an epitope tag that 
allows for side-by-side comparison of the binding proper- 
ties of the two proteins. Either h Rse-lgG or mRse-lgG was 
incubated with conditioned medium containing putative 
ligands. Complexes were captured with protein A (specific 
for the IgG fusion protein) and visualized with an antibody 
specific for the epitope-tagged putative ligand. While hGas6 
was bound by hRse-lgG, it was not efficiently bound by 
mRse-lgG (Figure 2). The reciprocal result was obtained 
in analysis of binding of hPS to hRse-lgG and mRse-lgG; 
hPS was bound by mRse-lgG but not by hRse-lgG. These 
results are consistent with an apparent difference in affin- 
ity of hPS for human as opposed to mRse/Tyro 3 (hPS 
prefers mRse/Tyro 3), as well as an inverse difference for 
hGas6 (hGas6 prefers hRse/Tyro 3). 
A second method was used to analyze quantitatively 
the interactions of hRse/Tyro 3 and mRse/Tyro 3 to hGas6 
and hPS. We measured the binding of ~2St-hRse-lgG or 
12~l-mRse-lgG to purified hGas6 or hPS using an assay 
in which complexes are captured with a method specific 
for the Gla domain present in hGas6 and hPS (barium 
coprecipitation) and in which these complexes are quanti- 
tated by virtue of the radioactivity in Rse-lgG. While hGas6 
bound ~2Sl-hRse-lgG efficiently, giving a half-maximal bind- 
ing at 8 nM hGas6, binding to 12Sl-mRse-lgG over the same 
concentration range was minimal (Figure 3A). In contrast, 
hPS was capable of binding 1251-mRse-lgG, although at 
considerably higher concentrations (half-maximal concen- 
tration of 90 nM), but bound very little 1251-hRse-lgG (Figure 
3B). We then compared the ability of increasing unlabeled 
hRse-lgG or mRse-lgG to compete for binding with fixed 
levels of 1251-hRse-lgG to hGas6 (Figure 3C). The binding 
of ~251-hRse-lgG to hGas6 was competed by low concen- 
trations of unlabeled hRse-lgG (IC~0 of 0.3 nM), but only 
by high concentrations of unlabeled mRse-lgG (IC~0 of 37 
nM). In contrast, the binding of 12Sl-mRse-lgG to hPS was 
competed by mRse-lgG (ICs0 of 18 nM) while hRse-lgG 
did not appear to compete at all (Figure 3D). These studies 
are entirely consistent with those shown in Figure 2. There 
was a profound difference in the affinities of hGas6 and 
hPS for the extracellular domains of mRse/Tyro 3 and 
hRse/Tyro 3, with hGas6 showing a preference for hRse/ 
Tyro 3 and hPS exhibiting a preference for mRse/Tyro 3. 
Similar results were obtained when the binding of hPS or 
hGas6 to receptor fusion proteins was analyzed by molec- 
ular interaction analysis using a stirred-cell optical sensor 
system (data not shown). 
hPS was reported to induce Rse/Tyro 3-mediated re- 
sponses in NIH 3T3 cells. We directly compared the ability 
of hPS or hGas6 to induce phosphorylation of hRse/Tyro 
3 or mRse/Tyro 3 expressed in NIH 3T3 cells. As noted 
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Figure 1. Comparison of Purified hGas6 and Purified Plasma-Derived 
hPS as Ligands for hRse/Tyro 3 
The indicated concentrations ofpurified recombinant hGas6 (closed 
circles) or plasma-derived hPS (open circles) (Enzyme Research Labo- 
ratories) were tested for ability to induce phosphorylation f hRse/Tyro 
3 expressed in CHO cells using an ELISA-based KIRA assay (see 
Experimental Procedures). Identical results were observed when hRse/ 
Tyro 3 phosphorylation was analyzed by immunoprecipitation using 
anti-Rse/Tyro 3 antibodies and Western blotting with anti-phospho- 
tyrosine antibodies. 
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Figure 2. Species-Specific Binding of Epitope-Tagged hGas6 and 
hPS by hRse-lgG and mRse-lgG 
Either hRse-lgG or mRse-lgG was incubated with unfractionated con- 
ditioned medium containing epitope-tagged hGas6 or hPS. Complexes 
were captured with protein A (specific for the IgG fusion protein) and 
fractionated by SDS-PAGE followed by Western blotting. Bound pro- 
teins were detected using the anti-g D antibody specific for the epitope- 
tagged putative ligand to compare directly the input and bound 
amounts of recombinant hPS and hGas6. The unfractionated (input) 
lanes represent 20% of the material used for the precipitation assay. 
Molecular sizes are indicated on the left (in kilodaltons). 
previously (Stitt et al., 1995; our unpublished data), phos- 
phorylation of hRse/Tyro 3 and mRse/Tyro 3 is observed 
upon treatment of cells with fetal bovine serum (FBS), indi- 
cating that both hRse/Tyro 3 and mRse/Tyro 3 expressed 
in NIH 3T3 cells are functional (Figure 4). Phosphorylation 
of hRse/Tyro 3 was not observed in response to high levels 
of either purified hPS or conditioned medium containing 
recombinant hPS, but was activated by conditioned me- 
dium containing hGas6. In contrast, mRse/Tyro 3 was acti- 
vated by purified hPS and by conditioned medium con- 
taining recombinant hPS, but not by medium containing 
hGas6. The level of hPS required to activate mRse/Tyro 
3 in our assays was significantly higher than that reported 
by Stitt et al. (1995) to activate mRse/Tyro 3 expressed 
in Rat2 cells. We note that in the studies reported here 
and by Stitt et al., the levels of recombinant hPS were 
estimated by comparison to purified hPS on Western blots. 
The concentration of hPS required to activate mRse/Tyro 
3 in the phosphorylation assay reported here is consistent 
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Figure 3. Solution Phase Binding of Recombinant hGas6 and Plasma-Derived hPS to hRse-lgG and mRse-lgG 
To measure saturation with ligand, increasing concentrations of hGas6 (A) or hPS (B) were mixed with a fixed amount (50,000 cpm) of l~SI-hRse/ 
Tyro 3 or ~251-mRse/Tyro 3, and precipitable radioactivity was measured as described in Experimental Procedures. Binding in (A) and (B) is expressed 
as 100 x BIT, where T is total radioactivity added and B is radioactivity recovered in the barium pellet. To measure inhibition of binding, 
concentrations of hGas6 and hPS were chosen to give 100 x BIT of 8-12. A constant amount of hGas6 and 12~l-hRse/Tyro 3 (C) or a constant 
amount of hPS and 12%hRse/Tyro 3 (D) was mixed with the indicated concentrations of hRse-lgG or mRse-lgG, barium precipitable radioactivity 
was measured as in Experimental Procedures, and binding was normalized to the percent of that obtained in the absence of added inhibitor with 
appropriate background subtraction (background of 3%-5% of total counts per minute). 
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Figure 4. Conditioned Medium from Cells Expressing hGas6 Induces 
Phosphorylation of hRse/Tyro 3 
Phosphorylation of mRseFFyro 3 is induced by purified hPS or by re- 
combinant hPS (rhPS). NIH 3T3 cells expressing either mRse/Tyro 3 
or hRse/Tyro 3 were serum starved and then left untreated (minus) 
or treated with 20% FBS or the indicated concentrations of hPS puri- 
fied from human serum or treated with conditioned medium from 293 
cells either mock transfected (M)or expressing recombinant hPS or 
recombinant hGas6 (rhGas6). The amounts of PS and Gas6 in the 
conditioned medium were estimated by Western blotting and by com-
parison to purified material of known concentration. 
with the relatively modest affinity of hPS for mRse/Tyro 3 
that we observe (see Figure 3). 
Rse/Tyro 3, along with the related receptors Axl/Ufo and 
c-Mer, comprises a family of receptor tyrosine kinases 
whose extracellular domains are reminiscent of neural cell 
adhesion molecules. Our data demonstrate that hGas6 is 
a bona fide ligand for hRseFFyro 3. Interestingly, hGas6 
has also been shown to activate human Axl/Ufo (Varnum 
et al., 1995; our unpublished data), and bovine Gas6 binds 
to the extracellular domain of murine Axl/Ufo (Stitt et al., 
1995). Thus, Gas6 appears to activate multiple receptor 
signaling pathways. 
We also demonstrate a pattern of reciprocal preferences 
between hRse/Tyro 3 and mRse/Tyro 3 and hPS and 
hGas6; hRse/Tyro 3 prefers hGas6 over hPS while mRse/ 
Tyro 3 prefers hPS over hGas6. One explanation for the 
inability of bovine Gas6 to bind to mRse/Tyro 3 (Stitt et al., 
1995) is that this interaction may be governed by species 
differences in receptor-l igand recognition. While our data 
that hPS binds to and activates mRse/Tyro 3 are in agree- 
ment with that of Stitt et al. (1995), the inability of hPS to 
serve as a ligand for hRse/Tyro 3 brings into question the 
conclusion that PS is a potent ligand for Rse/Tyro 3. Our 
results do not rule out the possibility that hPS might acti- 
vate hRse/Tyro 3 under certain circumstances. For exam- 
ple, modified forms of either the ligand or the receptor 
might behave differently than the versions we have tested. 
However, we have tested several sources of hPS (plasma- 
derived hPS from Enzyme Research Laboratories, Calbio- 
chem, and Celsus Laboratories, as well as recombinant 
hPS expressed in human 293 and CHO cells) and do not 
detect significant activation of hRse/Tyro 3. Given its ho- 
mology to Gas6, a potent ligand for Rse/Tyro 3, and the 
related receptor Axl (Varnum et al., !995), PS could yet 
prove to have a role as a physiologically relevant ligand 
for a member of the Rse/Axl family. 
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Experimental Procedures 
Construction and Expression of Recombinant Proteins 
hRse-lgG and mRse-lgG were constructed by fusing the sequence 
encoding amino acids 1-428 of hRseFFyro 3 or amino acids 1-418 of 
mRse/Tyro 3 (Mark et al., 1994) to amino acids 216-443 of human 
IgGyl. Epitope4agged gD.hPS or gD.Gas6 were constructed bylink- 
ing the coding sequences for the gD signal sequence and epitope tag 
(Mark et al., 1994) by polymerase chain reaction to coding sequences 
immediately before the first amino acid of mature hGas6 or hPS. Re- 
combinant proteins were expressed in stable 293 cells grown in serum- 
free medium. For purification, conditioned medium containing recep- 
tor-lgG proteins was mixed 1:1with Pierce ImmunoPure gentle Ag/Ab 
binding buffer and passed through a I mlHiTrap protein A-Sepharose 
column. Bound proteins were eluted with Pierce ImmunoPure eluting 
buffer and desalted on a Pharmacia PD10 column into phosphate- 
buffered saline (PBS). Protein concentration was determined by an 
anti-Fc enzyme-linked immunosorbent assay (ELISA). 
Binding Assays 
Immunoprecipitation with IgGfusion proteins was performed by mixing 
1 p.g of purified mRse-lgG or hRse-lgG with conditioned medium 
containing 150 ng of hGas6.gD or h PS.gD and 10 ~1 of protein A-Seph- 
arose CL4B (Pharmacia) ina final volume of 300 p,I. Binding was per- 
formed at 4°C on a shaker for 12 hr. Complexes were collected by 
centrifugation and washed three times with 0.5 ml of PBS with 0.1% 
NP-40. Proteins were separated byreducing SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) on Novex 4%-12% minigels, trans- 
ferred to nitrocellulose, and blotted with monoclonal anti-gD antibody 
as described previously (Mark et al., 1994). 
Iodination of Rse-lgG was performed using Iodobead (Pierce) oxi- 
dation of ~2SI-Nal; specific activity was 250-500 Ci/mmol. Binding stud- 
ies were performed by incubating samples containing hGas6 or hPS 
in 25 mM HEPES (pH 7.2), 0.1% BSA, and 0.05% Tween 20 with 
50,000 cpm of 12%mRse-lgG or '2~l-hRse-lgG and cold competitor (if 
any) in a total volume of 100-120 p.I.After 45 rain at room temperature, 
1 ml of a freshly prepared ice-cold suspension of BaC12 (10 mM) in PBS 
was added and precipitable radioactivity collected by c ntrifugation for 
4 min at 14,000 x g. 
Phosphorylation Assays 
CH 0 cell lines expressing a Rse.gD (which contains a C-terminal epi- 
tope tag recognized by antibody 5B6) were established and screened 
by Western blotting as described previously (Mark et l., 1994). An 
ELISA-based kinase receptor activation (KIRA) assay (Sadick et al., 
submitted) was established to measure quantitatively the ligand- 
induced phosphorylation of RseFFyro 3. CHO-Rse.gD cells were 
treated with potential ligand sources for 15 min, lysed with detergent, 
and transferred to surfaces coated with antibody 5B6. The degree of 
phosphorylation was quantitated using a biotinylated anti-phospho- 
tyrosine antibody (4G10; UBI), streptavidin conjugated to horseradish 
peroxidase (Zymed Laboratories), and a colorimetric peroxidase assay 
(two-component substrate kit; Kirkegard & Perry). Purified native hPS 
was obtained from Enzyme Research Laboratories. NIH 3T3 cells ex- 
pressing hRseFFyro 3 or mRse/Tyro 3 were established by infection 
of NIH 3T3 cells with a recombinant ecotropic retrovirus LXSN.hRse 
or LXSN.mRse encoding hRseFFyro 3 or mRse/Tyro 3, respectively. 
Retrovirat vectors were used toproduce populations consisting of hun- 
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dreds of thousands of stable clones to avoid the possibility that an 
individually selected clone might exhibit an aberrant phenotype. Ret- 
roviral stocks (titer of - 1 x 108 cfu/ml) were prepared, and 1 ml was 
used to infect 1 x 106 NIH 3T3 cells, which were selected as described 
previously (Pear et al., 1993). NIH 3T3.hRse or NIH 3T3.mRse cells 
were washed once in PBS and then cultured in high glucose DMEM 
without serum for 3 hr prior to treatment. Cells were treated with poten- 
tial ligand source for 5 min at 37°C. Conditioned medium containing 
hPS and hGas6 was concentrated 15-fold and then diluted 3-fold and 
30-fold to achieve the final concentrations, estimated to be 400 nM or 
40 nM, respectively. Control-conditioned medium concentrated 15-fold 
was used at a 3-fold dilution for the studies. Cells were washed once 
with cold PBS, lysates were prepared, and receptors were immunopre- 
cipitated with a polyclonal antibody that recognizes both hRse and 
mRse and were immunoblotted with an anti-phosphotyrosine antibody 
(4G 10; U BI). After incubation with an horseradish peroxidase-conju- 
gated anti-mouse IgG secondary antibody (Amersham), the phosphor- 
ylated proteins were revealed using a chemiluminescent detection 
method (ECL; Amersham). 
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